The Myasthenia Gravis Rare Disease Network, MGNet (U54 NS115054), announces its request for applications to two of its programs
The National Institutes of Health (NIH) awarded a research team at George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis. The team is led by Henry Kaminiski, MD (GW) and includes Linda Kusner, PhD (GW), Alison Hall, PhD (GW), Jeffrey Guptill, MD (Duke), Richard Nowak, MD (Yale), and Kevin O'Connor, PhD (Yale) as project leaders and executive steering committee members. This consortium will be one part of the larger Rare Diseases Clinical Research Network (RDCRN), funded by multiple NIH Institutes and Centers and led by NIH’s National Center for Advancing Translational Sciences (NCATS).
The Myasthenia Gravis Rare Disease Network, MGNet (U54 NS115054), announces its request for applications to two of its programs. The Pilot Grant Program will provide up to two grants of $75,000 to support clinical research dedicated to myasthenia gravis. The MGNet scholar program, designed to attract and enhance education of young investigators in the field of myasthenia gravis provides $78,000 per year renewable for a second year to support preparation for an independent career dedicated to rare disease research. Each program is supported by the core resources provided by MGNet and the NIH Rare Diseases Clinical Research Network Consortium.
Applicants must have a M.D. (or equivalent) or Ph.D. Clinical fellows, post-doctoral fellows, or junior faculty are eligible.
Applicants must identify a primary mentor with appropriate content expertise and experience mentoring young investigators.
Candidates should be U.S. citizens, U.S. permanent residents, or non U.S. citizens with a valid visa to work in the U.S. Scholars do not have be at a MGNet site.
Please visit https://ctsicn.org/funding/gw to view RFA and learn more
Myasthenia Gravis Network (MGNet) Scholar Program: Apply by November 20, 2020
Myasthenia Gravis Network (MGNet) Pilot Program: Letter of Intent due December 18, 2020